Chimeric Antigen Receptor Macrophage Therapy
This is an emerging cancer immunotherapy. Macrophages are modified using genetic engineering to enhance their ability to precisely identify and target tumor cells. CAR-M cell immunotherapy is currently a focus in the industry due to its significant advantages in treating solid tumors.
01
CAR-M targets HER2 to approach tumor cells.
02
CAR-M engulfs tumor cells, thereby exerting a tumor - killing effect.
03
CAR-M digests tumors and presents tumor antigens.
04
CAR-M presents antigens and releases factors that activate T cells.
05
The activated T cells then proceed to kill the tumor cells.
